Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Breakthrough Devices would no longer enjoy a fast track to Medicare inpatient new technology add-on payments (NTAPs) and outpatient pass-through payments under a proposal from CMS. If finalized, the change would likely lead to a massive drop of new awards from the bonus payment programs that have grown in recent years.
The eyonis LCS AI-enabled lung cancer screening application of Median Technologies, which recently gained FDA clearance, adds certitude to the diagnostic process, avoiding “watchful waiting” lags, and reducing anxiety-inducing false-positives, thereby lowering costs.
Next-gen start-ups treat heart failure tap into physiological mechanisms to help patients. Excerpted from our recent feature article.